KL and acute kidney injury: Likewise, Klotho gene-modified BM-MSCs could inhibit the Wnt-β/catenin pathway in TECs, and increase their proliferative and immuno-regulation capacities, suggesting a superior choice for cell therapy afterward I/R-induced AKI [168].